Abbott Laboratories (BIT:1ABT)

Market Cap	195.33B
Revenue (ttm)	36.71B
Net Income (ttm)	11.86B
Shares Out	n/a
EPS (ttm)	6.79
PE Ratio	16.47
Forward PE	24.06
Dividend	2.23 (1.98%)
Ex-Dividend Date	Jul 14, 2025

Volume	20
Average Volume	44
Open	113.90
Previous Close	114.70
Day's Range	112.88 - 113.90
52-Week Range	104.28 - 120.94
Beta	n/a
RSI	53.12
Earnings Date	Jul 16, 2025

About Redfin

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.